MDM2 and cancer: Although DDX5 is known to promote proliferation and tumorigenesis in other cancers, DDX5 downregulation also activates a pro-survival pathway involving mTOR and MDM2 signaling, leading to the inhibition of pro-apoptotic activity in HeLa cells [57], revealing the pleiotropic function of DDX5 depending on the cellular context.